Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Neurobiological Technologies Inc.

www.ntii.com

Latest From Neurobiological Technologies Inc.

2010 Scrip 100 - Survivors of the shakeout

Crunched credit wiped out many biotech firms in 2009, yet some emerged from the wreckage leaner and stronger. How did they do it, asks Dr Sukaina Virji-Jeganathan.

Metabolic Disorders Cancer

Recent Tech Transfer Deals (04/2008)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Recent Tech Transfer Deals (01/08)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Celtic Pharma Sees a Role for Private Equity in Biotech

The recently launched private equity firm Celtic Pharma aims to bridge the gap between biotech companies that have trouble financing R&D for mid- to late-stage projects and the Big Pharma firms desperate to rebuild their pipelines. The group's first fund, at around $1 billion, aims to bring together approximately 20 late-stage projects, take each through to regulatory approval, and license them out to the highest bidder.
BioPharmaceutical Clinical Trials
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Neurobiological Technologies Inc.
  • Senior Management
  • William A Fletcher, Acting CEO
    Matthew M Loar, CFO
    David E Levy, MD, VP, Clin. Dev.
  • Contact Info
  • Neurobiological Technologies Inc.
    Phone: (510) 595-6000
    2000 Powell St.
    Ste. 800
    Emeryville, CA 94608
    USA
UsernamePublicRestriction

Register